Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 2:46 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 500087 | NSE: CIPLA

Cipla Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹1,192.27Fairly Valued by 0.31%vs CMP ₹1,196.00

P/E (20.3) × ROE (17.8%) × BV (₹408.00) × DY (1.09%)

₹836.19Overvalued by 30.08%vs CMP ₹1,196.00
MoS: -43% (Negative)Confidence: 63/100 (Moderate)Models: 1 Under, 8 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹1,341.7122%Under (+12.2%)
Graham NumberEarnings₹718.8516%Over (-39.9%)
Earnings PowerEarnings₹419.2511%Over (-64.9%)
DCFCash Flow₹1,025.9913%Over (-14.2%)
Net Asset ValueAssets₹407.567%Over (-65.9%)
EV/EBITDAEnterprise₹1,013.769%Over (-15.2%)
Earnings YieldEarnings₹562.907%Over (-52.9%)
ROCE CapitalReturns₹577.989%Over (-51.7%)
Revenue MultipleRevenue₹511.595%Over (-57.2%)
Consensus (9 models)₹836.19100%Overvalued

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 12.5%

*Investments are subject to market risks

Investment Snapshot

64
Cipla Ltd scores 64/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health87/100 · Strong
ROCE 22.7% ExcellentROE 17.8% GoodD/E 0.08 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money45/100 · Moderate
FII holding down -2.35% (6mo) SellingDII holding up 2.56% MF buyingPromoter holding at 29.2% Stable
Earnings Quality55/100 · Moderate
OPM expanding (22% → 25%) ImprovingWorking capital: 128 days Capital intensive
Quarterly Momentum40/100 · Moderate
Revenue (4Q): +5% YoY GrowingProfit (4Q): -9% YoY DecliningOPM: 18.0% (down 10.0% YoY) Margin pressure
Industry Rank80/100 · Strong
P/E 20.3 vs industry 53.8 Cheaper than peersROCE 22.7% vs industry 16.4% Above peers3Y sales CAGR: 8% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 2:46 am

Market Cap 96,603 Cr.
Current Price 1,196
Intrinsic Value₹836.19
High / Low 1,673/1,194
Stock P/E20.3
Book Value 408
Dividend Yield1.09 %
ROCE22.7 %
ROE17.8 %
Face Value 2.00
PEG Ratio1.62

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Cipla Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Cipla Ltd 96,603 Cr. 1,196 1,673/1,19420.3 4081.09 %22.7 %17.8 % 2.00
Dr Reddys Laboratories Ltd 1,00,960 Cr. 1,210 1,380/1,02018.1 4320.66 %22.7 %18.0 % 1.00
Lupin Ltd 1,04,004 Cr. 2,275 2,378/1,77420.9 4300.53 %21.3 %20.6 % 2.00
Mankind Pharma Ltd 82,619 Cr. 2,001 2,727/1,91046.8 3760.05 %15.0 %13.9 % 1.00
Aurobindo Pharma Ltd 77,949 Cr. 1,342 1,360/99422.1 6030.30 %14.2 %11.1 % 1.00
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Cipla Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 5,8105,7396,3296,6786,6046,1636,6947,0517,0736,7306,9577,5897,074
Expenses 4,4034,5664,8354,9444,8564,8474,9785,1655,0845,1925,1795,6955,819
Operating Profit 1,4081,1741,4941,7341,7481,3161,7161,8861,9891,5381,7781,8951,255
OPM % 24%20%24%26%26%21%26%27%28%23%26%25%18%
Other Income 114-48136176-10249160191222289259269-70
Interest 32341626301818151514141314
Depreciation 272346239290233288247272280309253297278
Profit before tax 1,2187451,3751,5941,4741,2591,6111,7891,9161,5041,7701,854893
Tax % 34%30%28%28%28%26%27%27%17%19%27%27%24%
Net Profit 8085229981,1551,0689321,1751,3051,5751,2141,2921,353674
EPS in Rs 9.926.5112.3314.0113.0811.6314.5816.1319.4515.1316.0616.738.37

Last Updated: February 6, 2026, 8:13 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 23, 2026, 6:46 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 10,17311,34513,79014,39415,15616,36217,13219,16021,76322,75325,77427,54828,351
Expenses 8,0269,18311,31011,89812,32913,26513,92614,90717,21117,72619,48320,42021,886
Operating Profit 2,1472,1632,4802,4962,8263,0973,2064,2524,5535,0276,2917,1286,466
OPM % 21%19%18%17%19%19%19%22%21%22%24%26%23%
Other Income 25116420820828047734426699293552862747
Interest 146168207159114168197161106110906255
Depreciation 3735057541,3231,3231,3261,1751,0681,0521,1721,0511,1071,137
Profit before tax 1,8801,6541,7271,2221,6692,0792,1783,2903,4934,0385,7026,8216,021
Tax % 25%24%19%15%15%27%29%27%27%30%27%22%
Net Profit 1,4041,2291,3831,0351,4171,4921,5002,3892,5472,8334,1545,2694,533
EPS in Rs 17.2914.7116.9312.5117.5218.9619.1829.8231.1934.7151.0565.2856.29
Dividend Payout % 12%14%12%16%17%16%21%17%16%24%25%25%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-12.46%12.53%-25.16%36.91%5.29%0.54%59.27%6.61%11.23%46.63%26.84%
Change in YoY Net Profit Growth (%)0.00%24.99%-37.69%62.07%-31.62%-4.76%58.73%-52.65%4.62%35.40%-19.79%

Cipla Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:9%
5 Years:10%
3 Years:8%
TTM:6%
Compounded Profit Growth
10 Years:16%
5 Years:29%
3 Years:26%
TTM:21%
Stock Price CAGR
10 Years:9%
5 Years:17%
3 Years:15%
1 Year:-4%
Return on Equity
10 Years:13%
5 Years:15%
3 Years:16%
Last Year:18%

Last Updated: September 5, 2025, 2:00 am

Balance Sheet

Last Updated: December 4, 2025, 1:07 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 161161161161161161161161161161161162162
Reserves 9,89010,64111,35612,38314,06814,85115,60218,16520,68023,24626,54531,03232,757
Borrowings 1,2481,7035,2024,1134,0984,3162,8162,0141,056803559438467
Other Liabilities 2,1023,1664,3314,2134,3464,4334,8434,5144,9605,0895,2675,7026,778
Total Liabilities 13,40015,67021,04920,86922,67323,76223,42324,85526,85729,30032,53337,33440,164
Fixed Assets 6,4966,8309,3689,4929,9509,6089,6839,5169,6839,1609,60710,00610,933
CWIP 4425812,0611,6839816768259697661,0931,1531,5661,437
Investments 7096407599731,2592,5541,4712,7102,5513,6625,4497,9338,219
Other Assets 5,7537,6208,8628,72110,48310,92311,44411,66113,85715,38416,32317,82819,575
Total Assets 13,40015,67021,04920,86922,67323,76223,42324,85526,85729,30032,53337,33440,164

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 1,5631,1731,7412,3821,4631,6913,0683,7553,3263,2384,1345,005
Cash from Investing Activity + -1,265-950-4,533-1,304-834-1,688114-2,374-1,858-2,376-2,982-3,682
Cash from Financing Activity + -2661653,104-1,326-385-349-2,949-1,240-1,600-958-1,200-1,293
Net Cash Flow 33388312-248243-345234141-132-97-4930
Free Cash Flow 9975486881,2847231,1872,0832,9642,6452,1022,8193,490
CFO/OP 87%72%91%113%77%74%122%113%98%90%91%94%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow1.001.00-3.00-2.00-2.00-1.001.002.003.00-798.00-553.00-431.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 596462657593836657656873
Inventory Days 273329273239271250267232230228217231
Days Payable 92126106108142123139103108112102116
Cash Conversion Cycle 239267230196204220211195180181182188
Working Capital Days 9389-10991181321139495113120128
ROCE %19%15%13%7%9%11%12%17%17%18%23%23%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 33.55%33.46%33.46%33.46%33.46%30.91%30.93%29.19%29.20%29.19%29.22%29.22%
FIIs 27.42%25.49%25.74%25.73%25.82%27.82%28.80%26.65%26.28%25.24%24.54%23.93%
DIIs 21.83%24.05%23.90%24.05%24.15%24.66%23.95%27.49%27.89%28.98%29.98%30.45%
Government 0.21%0.21%0.21%0.21%0.21%0.21%0.21%0.23%0.26%0.27%0.27%0.27%
Public 16.99%16.76%16.68%16.53%16.36%16.40%16.11%16.43%16.36%16.30%15.99%16.12%
No. of Shareholders 4,75,2934,66,5154,26,8634,25,7314,36,1544,63,5694,70,2345,25,1145,43,4205,49,6555,34,5875,40,521

Shareholding Pattern Chart

No. of Shareholders

Cipla Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Flexi Cap Fund 21,000,000 2.85 2780.4N/AN/AN/A
Parag Parikh Flexi Cap Fund 12,623,339 1.25 1671.3310,989,5842026-02-23 04:01:4214.87%
HDFC Focused Fund 7,635,011 3.84 1010.886,000,0002026-02-23 04:01:4227.25%
SBI ELSS Tax Saver Fund 6,098,542 2.53 807.45N/AN/AN/A
ICICI Prudential Value Fund 5,500,126 1.21 728.224,746,6092026-02-23 04:01:4215.87%
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund 4,742,991 9.43 627.973,374,0562026-02-23 04:01:4240.57%
SBI Contra Fund 3,836,985 1.04 508.023,836,9852025-04-22 17:25:380%
Kotak Flexicap Fund 3,550,000 0.83 470.02N/AN/AN/A
Nippon India Pharma Fund 3,495,054 5.88 462.75N/AN/AN/A
Franklin India Focused Equity Fund 3,350,000 3.62 443.543,500,0002026-01-26 02:56:28-4.29%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 65.2951.0534.7231.2029.82
Diluted EPS (Rs.) 65.2451.0134.6931.1729.79
Cash EPS (Rs.) 79.2264.4949.6544.7643.02
Book Value[Excl.RevalReserv]/Share (Rs.) 386.25331.98293.79261.74230.46
Book Value[Incl.RevalReserv]/Share (Rs.) 386.25331.98293.79261.74230.46
Revenue From Operations / Share (Rs.) 341.10319.24281.89269.75237.58
PBDIT / Share (Rs.) 98.9387.1768.1759.9156.03
PBIT / Share (Rs.) 85.2374.1553.6546.8742.79
PBT / Share (Rs.) 84.4670.6250.0343.3040.80
Net Profit / Share (Rs.) 65.5251.4735.1331.7229.78
NP After MI And SOA / Share (Rs.) 65.2951.0534.7131.1929.82
PBDIT Margin (%) 29.0027.3024.1822.2123.58
PBIT Margin (%) 24.9823.2219.0317.3718.01
PBT Margin (%) 24.7622.1217.7416.0517.17
Net Profit Margin (%) 19.2016.1212.4611.7612.53
NP After MI And SOA Margin (%) 19.1315.9912.3111.5612.55
Return on Networth / Equity (%) 16.9015.4311.9612.0713.12
Return on Capital Employeed (%) 21.5721.7917.7817.0416.78
Return On Assets (%) 14.1012.599.509.289.56
Long Term Debt / Equity (X) 0.000.000.000.010.06
Total Debt / Equity (X) 0.000.010.020.030.08
Asset Turnover Ratio (%) 0.780.820.570.510.59
Current Ratio (X) 4.253.713.383.002.88
Quick Ratio (X) 3.222.712.371.911.86
Inventory Turnover Ratio (X) 5.061.000.810.700.87
Dividend Payout Ratio (NP) (%) 19.9116.640.000.000.00
Dividend Payout Ratio (CP) (%) 16.4513.260.000.000.00
Earning Retention Ratio (%) 80.0983.360.000.000.00
Cash Earning Retention Ratio (%) 83.5586.740.000.000.00
Interest Coverage Ratio (X) 128.8578.3050.2345.4528.12
Interest Coverage Ratio (Post Tax) (X) 86.3349.4028.5526.7815.94
Enterprise Value (Cr.) 115819.75120138.5271957.4681343.9366141.15
EV / Net Operating Revenue (X) 4.204.663.163.743.45
EV / EBITDA (X) 14.5017.0713.0816.8314.64
MarketCap / Net Operating Revenue (X) 4.234.683.193.783.43
Retention Ratios (%) 80.0883.350.000.000.00
Price / BV (X) 3.734.523.113.943.59
Price / Net Operating Revenue (X) 4.234.683.193.783.43
EarningsYield 0.040.030.030.030.03

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Cipla Ltd. is a Public Limited Listed company incorporated on 17/08/1935 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1935PLC002380 and registration number is 002380. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 19044.85 Cr. and Equity Capital is Rs. 161.52 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsCipla House, Peninsula Business Park, Mumbai Maharashtra 400013Contact not found
Management
NamePosition Held
Dr. Y K HamiedChairman
Mr. Umang VohraManaging Director & Global CEO
Mr. Kamil HamiedNon Exe.Non Ind.Director
Mr. Abhijit JoshiNon Exe.Non Ind.Director
Mr. Adil ZainulbhaiNon Exe.Non Ind.Director
Dr. Balram BhargavaIndependent Director
Dr. Mandar VaidyaIndependent Director
Ms. Maya HariIndependent Director
Mr. P R RameshIndependent Director
Mr. Robert StewartIndependent Director
Ms. Sharmila ParanjpeIndependent Director

FAQ

What is the intrinsic value of Cipla Ltd and is it undervalued?

As of 14 April 2026, Cipla Ltd's intrinsic value is ₹836.19, which is 30.08% lower than the current market price of ₹1,196.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (17.8 %), book value (₹408), dividend yield (1.09 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Cipla Ltd?

Cipla Ltd is trading at ₹1,196.00 as of 14 April 2026, with a FY2026-2027 high of ₹1,673 and low of ₹1,194. The stock is currently near its 52-week low. Market cap stands at ₹96,603 Cr..

How does Cipla Ltd's P/E ratio compare to its industry?

Cipla Ltd has a P/E ratio of 20.3, which is below the industry average of 53.84. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Cipla Ltd financially healthy?

Key indicators for Cipla Ltd: ROCE of 22.7 % indicates efficient capital utilization; ROE of 17.8 % shows strong shareholder returns. Dividend yield is 1.09 %.

Is Cipla Ltd profitable and how is the profit trend?

Cipla Ltd reported a net profit of ₹5,269 Cr in Mar 2025 on revenue of ₹27,548 Cr. Compared to ₹2,547 Cr in Mar 2022, the net profit shows an improving trend.

Does Cipla Ltd pay dividends?

Cipla Ltd has a dividend yield of 1.09 % at the current price of ₹1,196.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Cipla Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports